Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:21 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1CompletedINTERVENTIONAL

Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder

ClinicalTrials.gov · NCT04007224 · Registry updated: 2023-08-23

Condition / research focus: Autistic Spectrum Disorder
Sponsor: Fundatia Bio-Forum
Countries with listed sites: Romania
Registry dates and results: Start: 2019-01-17. Completion: 2023-07-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: non-invasive treatment
Autologous umbilical cord blood (biological) — also listed as: invasive treatment

Where the study takes place — 2 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Spitalul Angiomedica
Bucharest, Bucharest, Romania
Site recruitment: Not reported
Medicover Hospital
Bucharest, Romania
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

IV Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

ClinicalTrials.gov · NCT05608070 · Registry updated: 2023-08-14

Condition / research focus: Pain, Postoperative; Analgesia; Postoperative Pain; Pain, Post Operative; Oxytocin
Sponsor: Beth Israel Deaconess Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2023-06-01. Completion: 2025-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (drug) — also listed as: 0.9% NaCl, Saline

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

ClinicalTrials.gov · NCT05664659 · Registry updated: 2023-07-24

Condition / research focus: Blood Loss, Surgical; Intrapartum Hemorrhage
Sponsor: Ain Shams Maternity Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-12-20. Completion: 2023-05-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin + misoprostol (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Ain Shams Maternity Hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Brief Cognitive Behavioral Conjoint Therapy for PTSD With Adjunctive Intranasal Oxytocin

ClinicalTrials.gov · NCT05207436 · Registry updated: 2023-07-10

Condition / research focus: Post Traumatic Stress Disorder; Relational Problems
Sponsor: San Diego Veterans Healthcare System
Countries with listed sites: United States
Registry dates and results: Start: 2022-01-17. Completion: 2022-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Pitocin
Brief Cognitive-Behavioral Conjoint Therapy (behavioral) — also listed as: B-CBCT

Where the study takes place — 1 listed sites

VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Common and Differentiated Representations Between Social Exclusion and Social Separation

ClinicalTrials.gov · NCT05920707 · Registry updated: 2023-06-28

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2023-04-20. Completion: 2023-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug)
Intranasal Arginine Vasopressin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Cervical Ripening Balloon for 12 Hours vs. 1 Hour.

ClinicalTrials.gov · NCT05922111 · Registry updated: 2023-06-28

Condition / research focus: Induction of Labor
Sponsor: Rambam Health Care Campus
Countries with listed sites: No country reported
Registry dates and results: Start: 2023-08-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cervical ripening balloon for one hour (device)
cervical ripening balloon for twelve hours (device)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS

ClinicalTrials.gov · NCT03680339 · Registry updated: 2023-06-27

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-09-02. Completion: 2019-01-28 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cesarean section (procedure)
Misoprostol (drug) — also listed as: Cytotec
Oxytocin (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

ClinicalTrials.gov · NCT00963040 · Registry updated: 2023-06-15

Condition / research focus: Chronic Daily Headache
Sponsor: MedVadis Research Corporation
Countries with listed sites: United States
Registry dates and results: Start: 2009-11. Completion: 2010-08 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug) — also listed as: Oxytocin
Sterile water (drug) — also listed as: Placebo
Syntocinon (drug) — also listed as: Oxytocin
Sterile water (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

MedVadis Research Corporation
Wellesley Hills, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin Effects on Self Versus Other Touch

ClinicalTrials.gov · NCT05899517 · Registry updated: 2023-06-12

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2022-06-22. Completion: 2023-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oral lollipop with oxytocin (24IU) (drug) — also listed as: oral oxytocin
oral lollipop with placebo (drug) — also listed as: oral placebo

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section

ClinicalTrials.gov · NCT05110482 · Registry updated: 2023-06-06

Condition / research focus: Adverse Effect of Oxytocic Drugs
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-11-30. Completion: 2023-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Faculty of medicine CAIRO UNIVERISTY
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

ClinicalTrials.gov · NCT02255357 · Registry updated: 2023-06-05

Condition / research focus: Cocaine Dependence
Sponsor: New York State Psychiatric Institute
Countries with listed sites: United States
Registry dates and results: Start: 2015-03. Completion: 2018-02-14 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug)
Intranasal Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 2 listed sites

Substance Treatment and Research Service (STARS)
Manhattan, New York, United States
Site recruitment: Not reported
Divison on Substance Abuse - Albert Einstein College of Medicine
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome

ClinicalTrials.gov · NCT04283578 · Registry updated: 2023-06-01

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: Belgium · France · Germany
Registry dates and results: Start: 2020-03-10. Completion: 2022-03-14 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OT (drug) — also listed as: oxytocin
Placebo comparator (drug)

Where the study takes place — 7 listed sites

Cliniques Saint Luc
Brussels, Belgium
Site recruitment: Not reported
Hôpital Femme Mère Enfant
Bron, France
Site recruitment: Not reported
Hôpital Jeanne de Flandre
Lille, France
Site recruitment: Not reported
Hôpital de la Timone Enfant
Marseille, France
Site recruitment: Not reported
Groupe Hospitalier Necker - Enfants Malades
Paris, France
Site recruitment: Not reported
Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France
Site recruitment: Not reported
Klinik für Kinderheilkunde II
Essen, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome

ClinicalTrials.gov · NCT05298085 · Registry updated: 2023-06-01

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2022-04-05. Completion: 2023-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: oxytocin
Placebo (drug) — also listed as: placebo nasal spray

Where the study takes place — 4 listed sites

Hopital Jeanne de Flandre
Lille, France
Site recruitment: Not reported
Hôpital Femme-Mère-enfant Groupement hospitalier Est
Lyon, France
Site recruitment: Not reported
Chu Rouen
Rouen, France
Site recruitment: Not reported
CHU de Toulouse
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

ClinicalTrials.gov · NCT03651882 · Registry updated: 2023-05-24

Condition / research focus: Postpartum Hemorrhage
Sponsor: University of Zurich
Countries with listed sites: Switzerland
Registry dates and results: Start: 2018-08-07. Completion: 2022-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

University Hospital Zurich
Zurich, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin

ClinicalTrials.gov · NCT02465164 · Registry updated: 2023-05-22

Condition / research focus: Cervical Ripening
Sponsor: Henry Ford Health System
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-07-01. Completion: 2016-07-30 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cook catheter (device)
Oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.

ClinicalTrials.gov · NCT05864508 · Registry updated: 2023-05-18

Condition / research focus: Autism Spectrum Disorder
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2023-07. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)

Where the study takes place — 1 listed sites

Toulouse University hospital
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders

ClinicalTrials.gov · NCT05865288 · Registry updated: 2023-05-18

Condition / research focus: Eating Disorders
Sponsor: Shalvata Mental Health Center
Countries with listed sites: Israel
Registry dates and results: Start: 2023-06-30. Completion: 2025-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)

Where the study takes place — 2 listed sites

Shalvata Mental health Center
Hod HaSharon, Israel
Site recruitment: Not reported
Eating Disorder Clinic, Teradion
Misgav Regional Council, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Impact of Reading on Endogenous Oxytocin System of Preterm Infants

ClinicalTrials.gov · NCT05412524 · Registry updated: 2023-05-17

Condition / research focus: Premature Infant Disease; Development, Infant
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2022-09-23. Completion: 2024-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

reading (behavioral)

Where the study takes place — 1 listed sites

University of Virginia
Charlottesville, Virginia, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effects of Oxytocin Treatment on Social Touch

ClinicalTrials.gov · NCT05265806 · Registry updated: 2023-05-11

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2021-09-01. Completion: 2022-05-25 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Oxytocin intranasal spray
Oral oxytocin (drug) — also listed as: Oxytocin lingual spray
Placebo (drug) — also listed as: PLC

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Response of Preterm Infants to Multisensory Stimuli

ClinicalTrials.gov · NCT04665440 · Registry updated: 2023-05-10

Condition / research focus: Mother-Infant Interaction
Sponsor: University Hospital, Geneva
Countries with listed sites: Switzerland
Registry dates and results: Start: 2020-09-01. Completion: 2022-11-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Voice alone (other)
Voice + tactile stimuli (other)

Where the study takes place — 1 listed sites

Hôpitaux Universitaires Genève
Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:21 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1CompletedINTERVENTIONAL

Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder

ClinicalTrials.gov · NCT04007224 · Registry updated: 2023-08-23

Condition / research focus: Autistic Spectrum Disorder
Sponsor: Fundatia Bio-Forum
Countries with listed sites: Romania
Registry dates and results: Start: 2019-01-17. Completion: 2023-07-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: non-invasive treatment
Autologous umbilical cord blood (biological) — also listed as: invasive treatment

Where the study takes place — 2 listed sites

Spitalul Angiomedica
Bucharest, Bucharest, Romania
Site recruitment: Not reported
Medicover Hospital
Bucharest, Romania
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

IV Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

ClinicalTrials.gov · NCT05608070 · Registry updated: 2023-08-14

Condition / research focus: Pain, Postoperative; Analgesia; Postoperative Pain; Pain, Post Operative; Oxytocin
Sponsor: Beth Israel Deaconess Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2023-06-01. Completion: 2025-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (drug) — also listed as: 0.9% NaCl, Saline

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

ClinicalTrials.gov · NCT05664659 · Registry updated: 2023-07-24

Condition / research focus: Blood Loss, Surgical; Intrapartum Hemorrhage
Sponsor: Ain Shams Maternity Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-12-20. Completion: 2023-05-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin + misoprostol (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Ain Shams Maternity Hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Brief Cognitive Behavioral Conjoint Therapy for PTSD With Adjunctive Intranasal Oxytocin

ClinicalTrials.gov · NCT05207436 · Registry updated: 2023-07-10

Condition / research focus: Post Traumatic Stress Disorder; Relational Problems
Sponsor: San Diego Veterans Healthcare System
Countries with listed sites: United States
Registry dates and results: Start: 2022-01-17. Completion: 2022-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Pitocin
Brief Cognitive-Behavioral Conjoint Therapy (behavioral) — also listed as: B-CBCT

Where the study takes place — 1 listed sites

VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Common and Differentiated Representations Between Social Exclusion and Social Separation

ClinicalTrials.gov · NCT05920707 · Registry updated: 2023-06-28

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2023-04-20. Completion: 2023-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug)
Intranasal Arginine Vasopressin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Cervical Ripening Balloon for 12 Hours vs. 1 Hour.

ClinicalTrials.gov · NCT05922111 · Registry updated: 2023-06-28

Condition / research focus: Induction of Labor
Sponsor: Rambam Health Care Campus
Countries with listed sites: No country reported
Registry dates and results: Start: 2023-08-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cervical ripening balloon for one hour (device)
cervical ripening balloon for twelve hours (device)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS

ClinicalTrials.gov · NCT03680339 · Registry updated: 2023-06-27

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-09-02. Completion: 2019-01-28 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

cesarean section (procedure)
Misoprostol (drug) — also listed as: Cytotec
Oxytocin (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

ClinicalTrials.gov · NCT00963040 · Registry updated: 2023-06-15

Condition / research focus: Chronic Daily Headache
Sponsor: MedVadis Research Corporation
Countries with listed sites: United States
Registry dates and results: Start: 2009-11. Completion: 2010-08 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug) — also listed as: Oxytocin
Sterile water (drug) — also listed as: Placebo
Syntocinon (drug) — also listed as: Oxytocin
Sterile water (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

MedVadis Research Corporation
Wellesley Hills, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin Effects on Self Versus Other Touch

ClinicalTrials.gov · NCT05899517 · Registry updated: 2023-06-12

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2022-06-22. Completion: 2023-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oral lollipop with oxytocin (24IU) (drug) — also listed as: oral oxytocin
oral lollipop with placebo (drug) — also listed as: oral placebo

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section

ClinicalTrials.gov · NCT05110482 · Registry updated: 2023-06-06

Condition / research focus: Adverse Effect of Oxytocic Drugs
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-11-30. Completion: 2023-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Faculty of medicine CAIRO UNIVERISTY
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

ClinicalTrials.gov · NCT02255357 · Registry updated: 2023-06-05

Condition / research focus: Cocaine Dependence
Sponsor: New York State Psychiatric Institute
Countries with listed sites: United States
Registry dates and results: Start: 2015-03. Completion: 2018-02-14 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug)
Intranasal Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 2 listed sites

Substance Treatment and Research Service (STARS)
Manhattan, New York, United States
Site recruitment: Not reported
Divison on Substance Abuse - Albert Einstein College of Medicine
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome

ClinicalTrials.gov · NCT04283578 · Registry updated: 2023-06-01

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: Belgium · France · Germany
Registry dates and results: Start: 2020-03-10. Completion: 2022-03-14 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OT (drug) — also listed as: oxytocin
Placebo comparator (drug)

Where the study takes place — 7 listed sites

Cliniques Saint Luc
Brussels, Belgium
Site recruitment: Not reported
Hôpital Femme Mère Enfant
Bron, France
Site recruitment: Not reported
Hôpital Jeanne de Flandre
Lille, France
Site recruitment: Not reported
Hôpital de la Timone Enfant
Marseille, France
Site recruitment: Not reported
Groupe Hospitalier Necker - Enfants Malades
Paris, France
Site recruitment: Not reported
Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France
Site recruitment: Not reported
Klinik für Kinderheilkunde II
Essen, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome

ClinicalTrials.gov · NCT05298085 · Registry updated: 2023-06-01

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2022-04-05. Completion: 2023-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: oxytocin
Placebo (drug) — also listed as: placebo nasal spray

Where the study takes place — 4 listed sites

Hopital Jeanne de Flandre
Lille, France
Site recruitment: Not reported
Hôpital Femme-Mère-enfant Groupement hospitalier Est
Lyon, France
Site recruitment: Not reported
Chu Rouen
Rouen, France
Site recruitment: Not reported
CHU de Toulouse
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

ClinicalTrials.gov · NCT03651882 · Registry updated: 2023-05-24

Condition / research focus: Postpartum Hemorrhage
Sponsor: University of Zurich
Countries with listed sites: Switzerland
Registry dates and results: Start: 2018-08-07. Completion: 2022-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

University Hospital Zurich
Zurich, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin

ClinicalTrials.gov · NCT02465164 · Registry updated: 2023-05-22

Condition / research focus: Cervical Ripening
Sponsor: Henry Ford Health System
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-07-01. Completion: 2016-07-30 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cook catheter (device)
Oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum Disorders and Moderate to Severe Intellectual Disability: Feasibility and Safety Study.

ClinicalTrials.gov · NCT05864508 · Registry updated: 2023-05-18

Condition / research focus: Autism Spectrum Disorder
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2023-07. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)

Where the study takes place — 1 listed sites

Toulouse University hospital
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders

ClinicalTrials.gov · NCT05865288 · Registry updated: 2023-05-18

Condition / research focus: Eating Disorders
Sponsor: Shalvata Mental Health Center
Countries with listed sites: Israel
Registry dates and results: Start: 2023-06-30. Completion: 2025-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)

Where the study takes place — 2 listed sites

Shalvata Mental health Center
Hod HaSharon, Israel
Site recruitment: Not reported
Eating Disorder Clinic, Teradion
Misgav Regional Council, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Impact of Reading on Endogenous Oxytocin System of Preterm Infants

ClinicalTrials.gov · NCT05412524 · Registry updated: 2023-05-17

Condition / research focus: Premature Infant Disease; Development, Infant
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2022-09-23. Completion: 2024-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

reading (behavioral)

Where the study takes place — 1 listed sites

University of Virginia
Charlottesville, Virginia, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effects of Oxytocin Treatment on Social Touch

ClinicalTrials.gov · NCT05265806 · Registry updated: 2023-05-11

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2021-09-01. Completion: 2022-05-25 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Oxytocin intranasal spray
Oral oxytocin (drug) — also listed as: Oxytocin lingual spray
Placebo (drug) — also listed as: PLC

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Response of Preterm Infants to Multisensory Stimuli

ClinicalTrials.gov · NCT04665440 · Registry updated: 2023-05-10

Condition / research focus: Mother-Infant Interaction
Sponsor: University Hospital, Geneva
Countries with listed sites: Switzerland
Registry dates and results: Start: 2020-09-01. Completion: 2022-11-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Voice alone (other)
Voice + tactile stimuli (other)

Where the study takes place — 1 listed sites

Hôpitaux Universitaires Genève
Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →